International ‘A’ team debuts brain cancer atlas. Case Western Reserve University Press Release
Case Western Reserve Bioinformatics Expert Part of International “A” Team that Debuts Brain Cancer Atlas Experts and automated machine-learning techniques help glioblastoma research and treatment efforts June 4, 2018 VIEW…
TGen-Barrow study shows drug penetration of glioblastoma
PHOENIX, Ariz. — May 24, 2018 — In a first-of-its-kind clinical trial, a drug called AZD1775 was shown to penetrate deadly glioblastoma brain cancer cells, according to a study conducted at…
TGen develops quality-control test for detecting cancer in blood
PHOENIX, Ariz. — May 9, 2018 — Imagine how much patients could benefit if you could discover the presence of cancer, and even how that cancer develops over time, with a…
Brain tumor atlas published in the journal Science
PHOENIX, Ariz., and SEATTLE, Wash. — May 11, 2018 — This year, an estimated 13,000 Americans will be diagnosed with glioblastoma, which is the most deadly and aggressive form of brain…
An Intravascular magnetic wire for the high-throughput retrieval of circulating tumor cells in vivo
The detection and analysis of rare blood biomarkers is necessary for early diagnosis of cancer and to facilitate the development of tailored therapies. Nature Biomedical Engineering July 16, 2018 VIEW…
Prospective Feasibility Trial for Genomics- Informed Treatment in Recurrent and Progressive Glioblastoma
Glioblastoma is a rapidly progressing disease with poor outcome, with a median overall survival (OS) of less than 15 months for patients with newly diagnosed glioblastoma. Though glioblastoma is a…
Therapeutic form of arsenic is a potential treatment for deadly type of brain cancer
Use of arsenic trioxide could extend survival of some glioblastoma patients by three to four times historic median PHOENIX, Ariz. - Oct. 17, 2017 - From Sherlock Holmes to Agatha…